Comparative pharmacokinetics of the carbapenems : Clinical implications von MOUTON, Johan W, TOUW, Daan J, HORREVORTS, Alphonsus M, VINKS, Alexander A. T. M. M

Volltext

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome : A cost-effectiveness analysis von VAN LENT-EVERS, N. A. E. M, MATHOT, R. A. A, GEUS, W. P, VAN HOUT, B. A, VINKS, A. A. T. M. M

Volltext

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion von MOUTON, J. W, VINKS, A. A. T. M. M, PUNT, N. C

Volltext

Is continuous infusion of β-lactam antibiotics worthwhile?—efficacy and pharmacokinetic considerations von Mounton, Johan W., Vinks, Alexander A. T. M. M.

Volltext

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment : clinical outcome, microbiology and pharmacokinetics von VINKS, A. A. T. M. M, BRIMICOMBE, R. W, HEIJERMAN, H. G. M, BAKKER, W

Volltext

Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration von BERINGER, P. M, VINKS, A. A. T. M. M, JELLIFFE, R. W, SHAPIRO, B. J

Volltext

Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis: Current practice and suggestions for future directions von TOUW, D. J, VINKS, A. A. T. M. M, MOUTON, J. W, HORREVORTS, A. M

Volltext

High-performance liquid chromatographic method for the determination of colistin in serum von LE BRUN, Paul P. H, DE GRAAF, Alexandra I, VINKS, Alexander A. T. M. M

Volltext

166 DEVELOPMENT OF GENTAMICIN POPULATION MODELS FOR ICU AND NON-ICU PATIENTS USING A NON PARAMETRIC ALGORITHM (NPEM) von NAEM, Evers, AATMM, Vinks

Volltext

Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy von VINKS, A. A. T. M. M, MOUTON, J. W, TOUW, D. J, HEIJERMAN, H. G. M, DANHOF, M, BAKKER, W

Volltext

2 IMPACT OF GOAL-ORIENTED MODEL-BASED TDM OF AMINOGLYCOSIDES ON CLINICAL OUTCOME: A COST-EFFECTIVENESS ANALYSIS von Vinks, AATMM, Evers, NAEM, Mathôt, RAA, Michel, B C

Volltext

Can tobramycin inhalation be improved with a jet nebulizer? von LE BRUN, P. P. H, VINKS, A. A. T. M. M, TOUW, D. J, HEKELAAR, N, MANNES, G. P. M, BRIMICOMBE, R. W, FRIJLINK, E. H. W, HEIJERMAN, H. G. M

Volltext

Pharmacokinetics of once-daily amikacin dosing in patients with cystic fibrosis von Beringer, P M, Vinks, A A, Jelliffe, R W

Volltext

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home von VINKS, A. A. T. M. M, TOUW, D. J, HEIJERMAN, H. G. M, DANHOF, M, DE LEEDE, G. P. J, BAKKER, W

Volltext

Creatinine clearance as predictor of tobramycin elimination in adult patients with cystic fibrosis von TOUW, D. J, VINKS, A. A. T. M. M, JACOBS, F, HEIJERMAN, H. G. M, BAKKER, W

Volltext

128 ANALYSIS AND DOSING OF ANTIBIOTICS IN A RENAL PATIENT: CONTINUING EDUCATION THROUGH EQUAS von Vinks, AATMM, Eerland, J J, Harteveld, A R, Dijkhuis, I C

Volltext

Suggestions for the optimization of the initial tobramycin dose in adolescent and adult patients with cystic fibrosis von TOUW, D. J, VINKS, A. A. T. M. M, HEIJERMAN, H. G. M, HERMANS, J, BAKKER, W

Volltext

Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosis von TOUW, D. J, VINKS, A. A. T. M. M, HEIJERMAN, H. G. M, BAKKER, W

Volltext

196 IMPACT OF TDM OF ANTIBIOTICS ON CLINICAL OUTCOME: A COST-EFFECTIVENESS ANALYSIS von Evers, NAFM, Vinks, AATMM, Oeus, W P, Ledehoer, M, Smit, H P, Ruys, T, Michel, B C

Volltext

Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis von TOUW, D. J, VINKS, A. A. T. M. M, HEIJEMAN, H. G. M, BAKKER, W

Volltext